KNOWLEDGE BANK

Interviews

Datamonitor

Analyst
include the changing patent laws as countries aim to become more TRIPS compliant with India updating its law recently and China in the process of doing so through the WTO Increasing globalization of the generics market with Indian companies becoming involved in Europe and the US and vice versa will also provide an opportunity for generics companies

Articles

The Past, Present, and Future of Sickle-cell Disease Registries: Findings from a Global Review

Patient registries are important tools in the healthcare system for systematically collecting data over time from a population living with a certain disease condition or exposure Welldesigned and wellexecuted patient registries hold great potential in providing important disease insights into for example patient characteristics patterns of treatment and care

Research Insights

RNAi Therapeutic Platforms for Lung Diseases

Yu Fujita Fumitaka Takeshita Kazuyoshi Kuwano and Takahiro Ochiya Division of Molecular and Cellular Medicine National Cancer Center Research Institute Tokyo Japan Division of Respiratory Diseases Department of Internal Medicine Jikei University School of Medicine Tokyo Japan

Case Studies

Isolation Technology: Case Study

A customer active in the hormone production recently searched an appropriate solution for grinding material and clean packaging after the filtering and drying process The following requirements had to be met To provide a safe barrier between the operator and the active drug substance to provide both operator and product protect

Techno Trends

Janssen Pharma’s Niraparib Treats Patients with Prostate Cancer

A new orallyadministered poly ADPribose polymerase PARP inhibitor Niraparib has been launched by the Janssen Pharmaceutical Companies of Johnson Johnson

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

TOP ARTICLES

1

The Role of Artificial Intelligence in Advancing Pharmacovigilance Systems

Rahul Jaiswal

Rahul Jaiswal is an Assistant Professor at Hygia College of Pharmacy, Lucknow, and a Research Scholar at Integral University, Lucknow. He has been associated with CSIR-CDRI, Lucknow, and has published several articles. His expertise includes molecular techniques, histopathology, and innovative pharmaceutical research, with contributions to national and international conferences.

2

Nanoemulsion - A Promising Nanocarrier for Dermal Drug Delivery in Psoriasis

Sindhoor S M

Sindhoor S M is currently working as an Assistant Professor in the Department of Pharmaceutics at Sri Adichunchanagiri College of Pharmacy, Mandya, Karnataka. His areas of specialisation include nanotechnology-based drug delivery system, lipid-based formulations, Topical delivery and gastroretentive in situ gel systems. He has published eight papers based on nanotechnology and lipid-based drug delivery system in peer reviewed indexed journals. Presently he is involved in the development of lipid-based delivery systems.

 

Marina Koland

Marina Koland, is Professor and Head of the Department of Pharmaceutics at the NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to be University), Mangalore. Her area of specialisation in research is mucoadhesive and nanoparticulate drug delivery. She has published 50 research papers in peer reviewed journals, presented papers at 10 National and 3 International Conferences and worked on several Nitte University funded projects. She is currently working on solid lipid nanoparticles and micelles as drug carriers for targeting.

 

3

Homeopathic Science

Aditya Dilipkumar Patil

Aditya Dilipkumar Patil pursed B.H.M.S. and MD (Hom) from Bharati Vidyapeeth (Deemed to be University) Homoeopathic Medical College and Post Graduate Research Centre, Pune. He is currently working as Assistant Professor in Department of Homoeopathic Pharmacy at Dr.D.Y.Patil Homoeopathic Medical College and Research Centre, Pimpri, Pune 411018. He is a member of Chandrabhaga Charitable trust since 2017 and Life member of Moredada Charitable Trust, Nashik, Department of Herbal Medicine since 2018. He was working as Senior Research Fellow in Central Council for Research in Homoepathy (CCRH under Ministry of AYUSH). His main research work focuses on Evidenced based medicine, Diabetes, preclinical studies (In-vitro & In-vivo), nanoparticle etc.

 

Parth Sanjeev Aphale

Parth Sanjeev Aphale pursed B.H.M.S. from Dhondumama Sathe Homoeopathic Medical College and Research Centre, Pune and MD (Hom) from Foster Development Homoeopathic Medical College, Aurangabad. He is currently working as Professor in Department of Homoeopathic pharmacy at Dr.D.Y.Patil Homoeopathic Medical College and Research Centre, Pimpri, Pune 411018.

 

Dharmendra Basudeo Sharma

Dharmendra Basudeo Sharma pursed B.H.M.S. from Dhondumama Sathe Homoeopathic Medical College and Research Centre, Pune and MD (Hom) from University of Rajasthan and Ph.D from Maharashtra University of Health Science (MUHS). He is currently working as Principal and Head of Institute at Dr.D.Y.Patil Homoeopathic Medical College and Research Centre, Pimpri, Pune 411018.

 

4

The Unknown Sources of Error in the Pharmaceutical Weighing Process

Thomas Caratsch

Thomas Caratsch has been the Head of Laboratory Division since December 2007 at the company's headquarters in Greifensee, Switzerland. Prior to joining the company, Caratsch held various management positions within the Hoffmann La Roche group in the U.S. and Switzerland, including General Manager of Roche Instrument Centre AG and Head of Disetronic Medical Systems AG. He began his career as a development engineer at Sodeco-Saia in Geneva.

5

CAR-T Cell Therapy and NexCAR19

Ashwini Kumar

Dr Ashwini Kumar is presently working as an Assistant Professor in the Biotechnology and Bioinformatics Area at NIIT University, Neemrana (Rajasthan), India. Biomaterial science has been the main focus of Ashwini's research, particularly in the area of cutting-edge drug delivery techniques. His research's intended uses are developing minimally invasive and non-invasive medication delivery strategies to improve patient compliance and outcomes. Two other area that pique his curiosity are tissue engineering and diabetes. Ashwini is the author for twenty-two journal articles published in both domestic and foreign journals, eight book chapters, a book. In addition, he has a patent for his PhD work. He has been asked to participate in juries and speak on several national scientific venues. He has been working as a reviewer for reputable journals published by Frontiers, Elsevier, and Wiley. He is a guest editor of Frontiers in Medical Technology, a focused journal from Frontiers Publications, and a regular reviewer of Materials and Design, Elsevier. He is a life member of Asian Polymer Association.

 

press releasesRead more...

MindWalk Holdings Corp. (NASDAQ: HYFT) Launches ReefIQ™, a Biological Context Layer for AI Drug Discovery

MindWalk Holdings Corp MindWalk NASDAQ HYFT a bionative AI company today launched ReefIQ a HYFTpowered biological context layer for AI drug discovery and biologics development that sits between client discovery data

GENESIS Pharma Expands Strategic Commercial Partnership with Alnylam Pharmaceuticals for RNAi Therapeutics to the Nordic Region

GENESIS Pharma a leading regional biopharma company focused on the commercialization of innovative medicines in Europe today announced the expansion of its longstanding commercial partnership

Organon Secures US Food and Drug Administration Approval Expanding Indications for TOFIDENCE® (tocilizumab-bavi) in Cytokine Release Syndrome (CRS) and Pediatric COVID-19

Organon NYSE OGN today announced the US Food and Drug Administration FDA approval of the supplemental Biologics License Application sBLA for TOFIDENCE tocilizumabbavi injection for intravenous use a

Harbour BioMed Announces NMPA Acceptance of IND Application for HBM7004 for the Treatment of Advanced Solid Tumors

Harbour BioMed the Company HKEX a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology oncology and other disease areas

XtalPi Announces Strategic Partnership with a Leading Biopharma to Develop Oral Small Molecule Therapeutics for a GPCR Target

XtalPi HK a leading platform in artificial intelligence AI and roboticsdriven drug discovery today announced a strategic partnership with a prominent international biopharmaceutical company

SK bioscience Joins Forces with Global Institutions to Advance Rotavirus Vaccine Development

SK bioscience a global innovative vaccine and biotech company committed to promoting human health from prevention to cure today announced that after entering into a license agreement with the US Centers for Disease

EventsRead more...

09 - 11

Jun 2026

5th World ADC Summit South Korea

COEX Magok Lewest, 143 Magokju...

09 - 11

Jun 2026

World TPD & Induced Proximity Summit South Korea

COEX Magok Lewest, 143 Magokju...

09 - 11

Jun 2026

World Targeted Therapeutics Summit South Korea

COEX Magok Lewest, 143 Magokju...

10 - 11

Jun 2026

Novel Ingredients for Infant Nutrition Summit

The Westin Washington Dulles A...

10 - 11

Jun 2026

15 - 18

Jun 2026

MedTech Summit 2026

JW Marriott Hotel Berlin, Berl...

15 - 17

Jun 2026

Clinical Research 2026

Mercure Hotel MOA Berlin, Germ...

16 - 17

Jun 2026

LogiPharma Asia 2026

Equarius Hotel, Singapore

LATEST NEWSRead more...

Rewrite this news in-house style based on British English without Plagiarism, remove direct speeches, and Use simple and uncomplicated language as far as possible.

Orionis Biosciences has entered into an expanded multiyear collaboration with Novartis to discover and develop molecular glue medicines targeting difficulttotreat diseases across multiple therapeutic areas

PharmaEssentia Secures Taiwan Approval of BESREMi for Essential Thrombocythaemia

PharmaEssentia has received approval from Taiwans Ministry of Health and Welfare MOHW for BESREMi ropeginterferon alfabnjft to treat adult patients with essential thrombocythaemia ET

Antengene Receives China IND Approval for ATG-201 Autoimmune Disease Study

Antengene has received Investigational New Drug IND approval from Chinas National Medical Products Administration NMPA to begin the Phase I ATTRACT study of ATG a CD CD bispecific

Nxera Joins OpenFold AI Research Consortium to Strengthen Drug Discovery Capabilities

Nxera Pharma has joined OpenFold a nonprofit artificial intelligence research consortium focused on developing opensource AI tools for biology and drug discovery

Everest Medicines Enters into Agreement with Vcare PharmaTech for Sumecigrel

Everest Medicines has entered into an exclusive licensing agreement with Vcare PharmaTech for the development registration and commercialisation of Sumecigrel across the AsiaPacific region

Engitix and GSK Partner to Identify New Targets for Liver Fibrosis Regression

Engitix has entered into a strategic research collaboration and option agreement with GSK to identify and validate novel therapeutic targets aimed at promoting liver fibrosis regression